Back
  1. Home
  3. Detailled Reference
Download
Paper published in a journal (Scientific congresses and symposiums)
Cost-effectiveness of sequential treatment with abaloparatide followed by alendronate in US men at imminent risk of fracture.
Hiligsmann, Mickaël; Silverman, S.; Singer, A. et al.
2022 • In Journal of Managed Care and Specialty Pharmacy, 28, p. 105
Peer Reviewed verified by ORBi
Permalink
https://hdl.handle.net/2268/302045
 

Files (1)Send toDetailsStatisticsBibliographySimilar publications

Files

Full Text
Cost-effectiveness of sequential treatment with abaloparatide followed by alendronate in US men at imminent risk of fracture - abstract.pdf
Publisher postprint (1.7 MB)
Download

All documents in ORBi are protected by a user license.

Send to


Details


Disciplines :
Public health, health care sciences & services
Author, co-author :
Hiligsmann, Mickaël ;  UM - University of Maastricht [NL]
Silverman, S.
Singer, A.
Pearman, L.
Mathew, J.
Wang, Y.
Caminis, J.
Reginster, Jean-Yves  ;  Université de Liège - ULiège > Département des sciences de la santé publique > Santé publique, Epidémiologie et Economie de la santé
Language :
English
Title :
Cost-effectiveness of sequential treatment with abaloparatide followed by alendronate in US men at imminent risk of fracture.
Publication date :
2022
Event name :
NEXUS Congress of Academy of Managed Care Pharmacy (AMCP)
Event place :
National Arbor, United States
Event date :
11 to 14 october 2022
By request :
Yes
Audience :
International
Journal title :
Journal of Managed Care and Specialty Pharmacy
ISSN :
2376-0540
eISSN :
2376-1032
Publisher :
Academy of Managed Care Pharmacy (AMCP), Alexandria, United States - Virginia
Volume :
28
Pages :
105
Peer reviewed :
Peer Reviewed verified by ORBi
Available on ORBi :
since 25 April 2023

Statistics

Number of views
24 (2 by ULiège)
Number of downloads
12 (0 by ULiège)
More statistics

Bibliography

Similar publications


Contact ORBi